Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours
Condition:   Gastrointestinal Tumor Interventions:   Device: Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany);   Drug: tislelizumab (BeiGene, China) combined with PD-1 inhibitor Sponsors:   Pengyuan Liu;   Zhejiang Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials